Skip to main content

Peer Review reports

From: Azvudine versus paxlovid for oral treatment of COVID-19 in Chinese patients

Original Submission
26 Jun 2023 Submitted Original manuscript
26 Sep 2023 Reviewed Reviewer Report
3 Oct 2023 Reviewed Reviewer Report - Brett L. Hurst
7 Nov 2023 Author responded Author comments - Xing-guang Wang
Resubmission - Version 2
7 Nov 2023 Submitted Manuscript version 2
Publishing
14 Nov 2023 Editorially accepted
3 Jan 2024 Article published 10.1186/s12879-023-08828-2

You can find further information about peer review here.

Back to article page